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EDITORIAL REVIEW
Evaluation of lithium clearance as a marker of proximal tubule
sodium handling
Since the employment of direct approaches such as micro-
puncture [1] and microperfusion [2] our understanding of tubu-
lar filtrate processing has advanced greatly. Each of these
methods has its own merits. However, disturbing factors such
as anesthesia and preparation of the study target are recognized
[2, 3]. Clearly, humans cannot be studied in this way. Therefore
the need for indirect methods remains, but the information
obtained with such methods is necessarily limited, not very
precise, and often uncertain.
In the late sixties [4, 5] and again more recently [6, 71 lithium
clearance was advanced as a method to estimate quantitatively
sodium and water delivery from the proximal tubules ("end-
proximal tubule delivery") in the mammalian kidney by Thom-
sen and colleagues. Since conventional indirect methods, such
as the renal clearance of phosphate, calcium, uric acid, and
maximal free water clearance, do not allow quantitative esti-
mation of proximal tubule solute reabsorption, this would imply
major improvement of our study tools [8]. The current veritable
explosion of studies using lithium clearance illustrates the need
for such improved methods.
There are certainly many arguments in favor of the lithium
clearance method. Both lithium and sodium are primarily
reabsorbed in the proximal tubules, and, as will be discussed,
by and large good correlations exist between lithium reabsorp-
tion and (expected) proximal tubule sodium reabsorption. How-
ever, much evidence is circumstantial, and as pointed out
recently by Navar and Schafer [9] there is insufficient proof for
unconditional acceptance of the method. For instance, it is
doubtful that lithium reabsorption beyond the proximal tubules
does not occur at all. Specifically, it may be questioned whether
subtle or even large changes in lithium clearance purely reflect
changes in proximal tubule sodium handling. Clearly this ques-
tion should be answered before firm conclusions can be drawn
from lithium clearance data. In this overview we will try to
define possibilities and limitations of the lithium clearance
method.
Criteria to be fulfilled
An ideal marker of proximal tubule sodium reabsorption
should fulfill the following criteria: I) no influence on renal
function, 2) free filtration in the glomerulus, 3) reabsorption in
proportion to sodium and water along the entire proximal
tubule, 4) no reabsorption beyond the proximal tubules, and 5)
absence of tubular secretion.
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Equilibration experiments using cellulose membranes have
shown that the lithium ion does not bind to plasma proteins and
therefore can freely pass the glomerular membrane [10]. In
human plasma trace amounts of lithium (—0.2 &Eq/liter) are
present [11, 12] which are difficult to measure. For study in
humans it is customary to give 0.1 to 0.2 mEq lithium/kg orally
as a lithium-salt approximately 12 hours before clearance stud-
ies [13—20]. This results in accurately measurable and stable
concentrations of 0.1 to 0.3 mEq/liter, declining by 3 to 6% per
hour during clearance studies. Similar methods have been used
in rats and dogs to obtain levels of 0.2 to 0.6 mEq/liter [2 1—28].
However, sometimes much higher doses have been used,
yielding concentrations above I mEq/liter [29, 30] or even
around 4 mEq/liter [3 1—33]. Plasma lithium concentrations
above 2 mEq/liter acutely affect renal electrolyte handling. In
general increased sodium and potassium excretion, proton
retention and decreased water reabsorption have been found
[34-39]. No effect was found on maximal water excretion in
man [38] and non-human primates [39], but it appeared in-
creased in rats [36]. In micropuncture-studied rats, proximal
tubule solute reabsorption was markedly diminished during
plasma lithium concentrations ranging from 2 to 3 mEq/liter
[35]. Users of the lithium clearance method generally assume
that such effects are absent with plasma concentrations below
0.4 mEq/liter, but this has not been studied systematically. In
fact, a recent study in humans showed that even such low
lithium levels may have some natriuretic effect [40].
Most attention in this review will be given to the other three
criteria. Subsequent nephron segments will be addressed.
Available data on renal lithium handling generally apply to
rats, dogs, and humans, on which species we will focus. The
referenced data obtained in our department have, unless indi-
cated otherwise, been collected in recumbent humans, during
maximal water diuresis, and after a single oral lithium dose as
indicated above.
Proximal tubule
Measurements of lithium transport along the proximal tubule
Lithium does not substitute for sodium in the (Na+K)-
ATPase of rat kidney [41] or frog skin [42]. Partial or complete
substitution of sodium by lithium in perfusate and peritubular
fluid partially or completely prevented fluid reabsorption in
proximal tubules [43, 44]. Thus lithium, in contrast to sodium,
is not actively transported in this nephron segment. In rat
proximal tubules perfused with a lithium and 22sodium contain-
ing solution, the escape rates of these ions out of the tubule
were similar [44]. Also, simultaneously measured lithium and
volume absorption along the rat proximal nephron were pro-
portional [31]. Thus, although the proximal tubule does not
Fractional lithium excretion, x 100%
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Fig. 1. Means SD for fractional sodium and
lithium excretion from those studies where both
variables were available. Capitals denote
different studies: A. Kirchner [47]; B, Steele et
al [30]; C, Dieperink et al [46]; D, Biollaz et al
(65]; E, Hayslett et al 1311; F, Thomsen et al
128]; G, Christensen et al [24]; H, Steele et al
[33]; 1, Haas et al [26]. Note the steep relation
between fractional sodium and lithium excretion
when fractional sodium excretion is below 1%.
reabsorb lithium actively, it would transport lithium at the same
rate as sodium and water. This is remarkable, since the reab-
sorption of lithium, in contrast to that of sodium, at least partly
concerns transport along a concentration gradient. Truly pro-
portional reabsorption of both ions would implicate either
identical handling of lithium and sodium or a very high perme-
ability to lithium. Since the mammalian proximal nephron is a
"leaky" epithelium, the lithium reabsorption most likely occurs
passively via the paracellular route [44, 45].
Direct measurement of lithium transport is necessarily lim-
ited to the part of the proximal tubule accessible to micropunc-
ture. Hayslett and Kashgarian [31] found in non-diuretic rats
that about 57% of the filtered lithium had been reabsorbed at the
late proximal convoluted tubule, in proportion to sodium and
water. Another 18% had been reabsorbed at the early distal
tubular level, and comparison with urinary lithium suggested
that no further lithium reabsorption had occurred beyond this
site. Whether the additional 18%, one-fourth of total lithium
reabsorption, had been reabsorbed in the remainder of the
proximal tubule or in Henle's loop, or both, is uncertain.
Lithium clearance and directly assessed proximal solute
reabsorption
In five different laboratories it was found with micropuncture
studies in rats that fractional solute reabsorption at the latest
accessible superficial proximal tubules was 73 to 82% of the
fractional (whole kidney) lithium reabsorption in the same or
similarly studied rats [26, 28, 31, 46—48]. The fractional lithium
excretion (FELl) in such rats (normal sodium diet) averaged 25
to 35% [24, 28, 29, 31—33]. According to the lithium clearance
method proximal reabsorption would thus comprise 65 to 75%
of the filtrate. In superficial nephrons about one-fourth to
one-fifth of this reabsorption would occur in the pars recta. The
latter prediction cannot be substantiated directly, but does not
seem unreasonable when length and reabsorption rate of this
particular segment are taken into account [49, 50]. In general,
these quantitative estimations are in favor of the lithium clear-
ance concept, but it must be recalled that segmental sodium and
lithium reabsorption may be different in deep nephrons in view
of anatomical and functional internephron heterogeneity [50].
In a few of these rat studies the effects of maneuvers on FELl
and micropuncture-assessed end-proximal solute delivery were
measured simultaneously. It was found that the two variables
increased comparably after volume expansion [28, 47], and
decreased comparably during chronic thiazide treatment [483, in
favor of the lithium clearance method. However, another such
study showed that lowering of renal perfusion pressure de-
creased FELl, while directly measured proximal tubule reab-
sorption did not change [26]. This was explained as a different
response in superficial nephrons and in (micropuncture-inacces-
sible) deep nephrons [26]. Also, in one of these studies it
appeared that sodium restriction reduced FEL, further than
expected from late proximal tubule solute reabsorption [47].
Amiloride could prevent this excessive drop in FELl, which
suggests that this concerned "distal" lithium reabsorption
rather than a different response in superficial and deep nephrons
[47].
Studies comparing FEL to directly measured proximal solute
reabsorption in other species are not available. Our further
information on the (in-)validity of the lithium clearance concept
is indirect, based on effects on lithium clearance during maneu-
vers supposedly affecting or not affecting proximal reabsorp-
tion.
Measurements of lithium clearance, effect of sodium intake
FEL, in rats on normal sodium intake is 25 to 35% [24, 28, 29,
3 1—33]. Increased sodium intake is accompanied by a rise in
FEL, which is consistent with the expected increase in sodium
delivery from the proximal tubules, but in rats subjected to
various degrees of sodium restriction FELl drops disproportion-
ately [47, 51, 52]. Figure 1, giving means of fractional sodium
excretion (FENa) and FELl from studies in rats where both
variables were available, illustrates that this is the case when
FENa becomes lower than —1.0%. FELl may attain very low
values, and it is unlikely that this is due to enhanced proximal
lithium reabsorption. This appears in fact impossible, since in
water-loaded rats sodium restriction lowered the urinary to
plasma lithium concentration ratio (U/PLI ratio) below 1 [51,
52]. "Distal" lithium reabsorption is thus likely, consistent with
the observation that amiloride could prevent this extreme drop
in FEL, [47, 52].
Means for FELl in dogs on regular diet vary between 22 to
38% [21, 22, 25, 27, 53—55]. Reabsorption at the late proximal
tubule amounts to 40 to 45% of filtrate [56, 57] in euvolemic
dogs. Together these data would suggest that the relative
contribution of the pars recta to total proximal solute reabsorp-
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Fig. 2. Fractional excretion of sodium of lithium (FE,111,1,,,,)
and of maximal urine flow (FE,.U,) in normal humans (n = 131) on
varying sodium intakes. Data published partially in reference 63.
tion is roughly twice as much in dogs as in rats. Alternatively,
a greater portion of lithium reabsorption may take place in the
"distal" nephron. As in rats, sodium restriction in dogs causes
a sharp drop in FELl [54].
In recumbent humans consuming normal sodium diet, means
of FELl given in individual studies range from 27% to 38% [13,
15, 16, 18, 19, 58]. Direct information on proximal tubule
sodium handling is obviously unavailable. In the rhesus monkey
it was estimated by micropuncture that end-proximal (—92% of
total proximal tubule length) sodium reabsorption was 70% of
filtered sodium [591. Together these data are reconcilable with
the lithium clearance concept. FELl increases with increased
salt intake [6, 13, 60], but in contrast to findings in rats and dogs
there is no sharp drop during salt restriction. Instead, with
decreasing FENa, FELl decreases gradually to values ranging
between 18 and 25% (Fig. 2). Such values are also found in
sitting or ambulant humans [14, 18, 201, and posture should be
defined in human studies.
Thus, with the exception of findings in sodium-restricted rats
and dogs, there seems a reasonable quantitative agreement
between FELl and the expected solute delivery from proximal
tubules. Without doubt FEL gives a more acceptable estimate
than any other indirect marker, including the maximal water
diuresis method. Figure 2 demonstrates that the latter method
would estimate "distal delivery" 50% lower than FELl over a
whole range of sodium excretion. This further supports the
lithium clearance method, since vasopressin-independent water
back diffusion has been estimated about half of the distal fluid
delivery [61]. Interestingly, for any sodium excretion rate there
is a large interindividual variation in both FELl and maximal
urine flow (Fig. 2). However uncertain the quantitative meaning
of these variables may be, this would imply that even among
normal individuals with equal sodium excretion rates renal
sodium handling may vary greatly. Indeed, the intra-individual
variability in FELl during varying sodium intake seems much
less than inter-individual variability [62].
Lithium clearance and interventions
Maneuvers supposedly altering proximal sodium reabsorp-
tion generally alter FELl as well. For example, FELl is in-
creased by saline infusion [15, 16, 32, 47, 58],sodium loading [6,
13, 47, 60, 63], volume expansion by mineralocorticoid [64—66],
hypotonic expansion with antidiuretic hormone [67], and de-
creased by low sodium intake [13, 60], volume depletion due to
chronic thiazide administration [48, 68, 69], acute elevation of
plasma oncotic pressure [70], acute lowering of renal perfusion
pressure [26], and upright posture [18].
Clearly, without direct information on proximal tubule reab-
sorption any change in FELl by above-mentioned maneuvers
can at best provide indirect support for the lithium clearance
method. Only when the magnitude of such a change corre-
sponds with the expected change in proximal reabsorption is
this additional proof for the reliability of the lithium clearance
method. That this is not always the case appears when different
expansion models are compared. In two groups of healthy
adults expanded by continued administration of mineralocor-
ticoid or the vasopressin analogue dDAVP [detailed data in 66,
67] we found comparable increments in GFR and fractional
phosphate clearance, and somewhat more rise in fractional
excretion of uric acid after dDAVP (Table 1). The rise in FELl,
however, was exceptionally large after mineralocorticoid ex-
pansion, which is in confirmation of an early observation in rats
[64]. The rise in "distal delivery" derived from urine flow or
free water clearance was not nearly as large, and the normal
relation between FELl and maximal urine flow (Fig. 2) com-
pletely disturbed. Whatever the correct explanation, it is un-
likely that this huge rise in FELl during mineralocorticoid
escape resulted from suppressed lithium reabsorption in the
proximal tubules alone.
Conclusive support for the lithium clearance method cannot
be expected from pharmacological studies since drug actions
are hardly ever confined to a single nephron segment. Aceta-
zolamide induces a marked rise in FELl [32, 33, 47, 52], and the
major action of this carbonic anhydrase inhibitor undoubtedly
concerns the proximal tubules. Yet, neither is carbonic anhy-
drase confined to the proximal tubules [71], nor can an effect of
increased bicarbonate delivery on potential "distal" lithium
handling be excluded. Many diuretics which increase FELl
acutely have, besides specific actions in the distal parts of the
nephron, a suppressive effect on proximal solute reabsorption
as well. These will be considered below. Micropuncture studies
in dogs [72] have localized suppression of sodium reabsorption
during osmotic diuresis in Henle's loop rather than the proximal
tubule. Thus, the large increase in FELl after urea infusion in
normal man [4] lends no real support for the lithium clearance
method. Finally, subpressor doses of angiotensin II, which
probably increases proximal tubule sodium reabsorption [73],
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Table 1. Lithium clearance and other renal function parameters during various maneuvers in healthy humans
8 days of 9-fludrocortisone 8 days of dDAVP 8 days of indomethacin 50 mg iv. furosemide(N=8) (N=8) (N=8) (N=7)
Control Experiment Control Experiment Control Experiment Control Experiment
C111 mI/mm 125 II 149 l5 110 14 135 23' 115 8 107 5 119 13 132 I9
V/C111% 16 2 20 Y' — — 12 3 9 2 12 3 35 3a
FEIIhI, % 33 4 50 9 28 6 35 6 30 2 21 2 29 6 54 4
FEodium % 2.0 0.5 2.3 0.8 1.4 0.5 2.0 0.5a 0.7 0.1 0.8 0.1 1.2 0.7 25.1 3.8a
FEphophate% 6.0 2.7 8.1 2.7a 8.5 4.7 11.5 4.l 7.8 2.6 8.9 3.7 7.5 3.2 22.8 7.6a
FEuricacid% 9.6 2.3 11.3 2.9a 8.5 3.2 14.0 1.4k 9.9 2.1 I0.l 1.8 8.7 2.0 15.4 37a
UNa V /2mo/Imin 361 69 518 214 221 83 348 126 119 23 119 21 203 112 4560 585
Uom mOsm/kg 69 4 54 8a — — 61 6 90 7 62 5 216 a
Study conditions: 9-fludrocortisone 0.5 mg orally bid for 8 days; d-DAVP 20 tg intranasally tid for 8 days; indomethacin 50 mg orally tid for 8
days; furosemide 50 mg acutely i.v. Further details in [66, 67, 84, 88]. Abbreviations are: C, clearance; FE, fractional excretion; U, urine; V, urine
flow; osm, osmolality.
a P < 0.05 before and after maneuvers
lowers FELl in dogs [27]. However, as will be considered,
interference with sodium reabsorption in Henle's loop also by
this substance cannot be excluded.
Loop of Henle
Lithium transport along the loop of Henle
The net lithium reabsorption between late proximal convo-
lute and early distal tubule as found by Hayslett and Kashgarian
[31] in rat superficial nephrons may have occurred in either pars
recta or Henle's loop or both. Some direct information is
available on lithium transport along Henle's loop. Lithium
could substitute for sodium in the Na2ClK cotransporter in
membrane vesicles of medullary thick ascending limb [74] and
MDCK cells [75]. Lithium transport in the thick ascending limb
is therefore not impossible. Part of the sodium reabsorption in
this segment concerns voltage driven transport via a cation-
selective paracellular pathway [76]. Therefore it is not unrea-
sonable to assume passive lithium reabsorption in this segment.
Importantly, permeability characteristics of superficial neph-
ron short loops probably differ from those in deep nephron long
loops of Henle. Only of the latter, both thin descending and
ascending limbs are permeable to sodium and (only slightly less)
to lithium in rats and hamsters [77—79]. Passive lithium reab-
sorption may occur here, but as clarified by Imai, Taniguci and
Tabei [78] by means of computer analysis, such permeability
characteristics say little about occurrence and direction of net
transport in vivo. Assuming that the concentration of sodium
along the thin descending limb increases by --2.5-fold, they
concluded that sodium diffuses passively out of both descend-
ing and ascending thin limbs. The magnitude of this passive
transport depends upon the magnitude of the cortico-medullary
concentration gradient, and thus would increase with sub-
stances such as vasopressin and cyclooxygenase inhibitors
which promote the gradient, and decrease with osmotic or loop
diuretics. Potassium, in contrast to sodium, diffuses into the
thin descending limb of long loops [78]. Whether and in which
direction lithium takes part in this transport is unknown.
However, transport in a way comparable to sodium is suggested
not only by the high permeability, but also by the finding of a
similar cortico-papillary gradient for lithium as for sodium in
dogs [80] and rats [81]. In any case, if there is net transport of
lithium in these thin segments, it may be confined to the
juxtamedullary nephrons not accessible to micropuncture.
Lithium clearance and interventions
It is of course attractive to use "loop diuretics" to analyze
the possibility of lithium transport in this segment, but it is by
no means certain that their action is limited to the loop. In fact,
some of them, such as furosemide, have carbonic anhydrase
inhibiting properties, and probably also act on the proximal
tubule [76, 82, 83]. In most studies furosemide was found to
elevate FELl markedly [17, 23, 24, 33, 47, 58, 84]. We found a
tremendous increase in FELl after acute intravenous adminis-
tration of 50 mg furosemide in healthy humans [84]. Besides a
large natriuresis the data (Table 1) also showed markedly
increased phosphate and uric acid excretion, compatible with a
proximal action of this drug. Nonetheless, the rise in FELl was
such that part of the effect was probably due to abolishment of
pre-existing lithium transport in Henle's loop.
Several studies assessed the influence of the volume state on
lithium excretion induced by furosemide. Christensen et al [23]
found in rats in which FENa and FEL, had been increased by
saline infusion, that furosemide could further raise FENa but
not FELl. Comparable findings were made by Atherton et al [131
in humans. They showed that during low sodium diet furo-
semide increased both FENa and FELl, but when FENa and
FELl were increased previously by high sodium diet or saline
infusion, furosemide raised only FENa further. On the one
hand, this suggests that furosemide did not further suppress
proximal tubule reabsorption already low due to volume load-
ing. On the other hand, it would imply that volume expansion
abolished any lithium reabsorption occurring in Henle's loop.
Kirchner [47] found that in sodium restricted rats furosemide
raised FELl so much that it exceeded fluid delivery to micro-
punctured late proximal tubules. Acetazolamide also raised
FELl, but without showing this discrepancy. Together, these
data suggest that sodium restriction promotes lithium reabsorp-
tion particularly in the deep loops of Henle, which can be
interrupted by furosemide.
The interaction of other 1oop diuretics with lithium clearance
has hardly been studied. Ethacrynic acid had no effect on FELl
in one study [4]. In contrast, we found that both ethacrynic acid
6 Kooinans er a!: Lithium clearance and Na handling
0
0.53
*
0.09
Control
0.36
*
0.08
lndomethacin
101
27.6
*
1.0
Control
21.8
÷
1.0
lndomethacin
as bumetanide cause large increases FELI comparable to furo-
semide in healthy adults (WH Boer et at, unpublished data).
Other evidence for lithium reabsorption in the loop comes
from studies with other classes of drugs. Prostaglandin synthe-
sis inhibitors reduce lithium clearance in patients on lithium
treatment [85—87]. In healthy humans taking indomethacin
chronically we found unaltered FENa but markedly reduced
FELl [88]. Maximal urine flow was also reduced (Table 1), but
to a lesser extent than FELl. Fractional clearances of phosphate
and uric acid were not decreased, in agreement with the idea
that prostaglandin synthesis inhibitors do not interfere with
proximal solute handling [89—91]. However, these drugs in-
crease medullary thick ascending limb reabsorption [76, 89, 91—
93] and diminish papillary blood flow [94, 95], thus intensifying
the cortico-medullary osmotic gradient. Therefore increased
lithium reabsorption may very well have occurred in the loop,
either in the thin descending and ascending limbs, or in the
medullary thick ascending limb. We also found that indometh-
acm in humans reduces FELl acutely, even when initial FENa is
relatively high [96]. Figure 3 summarizes the data. An effect of
multiple cyclooxygenase inhibitors on lithium clearance has
been denied in a recent study in rats [97]. A methodological
problem seems likely, as other widely appreciated effects on
renal function, such as increased urine osmolality, were also
absent in that study. Earlier studies in rats from another
laboratory showed a fall in FELJ after indomethacin [981.
Vasopressin has no effect on proximal tubule solute reabsorp-
tion [99] and would not influence lithium reabsorption if this
occurred exclusively in the proximal tubule. Yet, in water-
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Fig. 4. Fractional sodiu,n and lithium excretion and
before and after 4 g intravenous dDA VP (I-desamino-8-D-arginine
vasopressin) in healthy humans (N = 31) on varying sodium intakes.
Means SD are presented below the Figure and were significantly
different for FESOdèOm (P < 0.01) and FE)j,hUfl, (P < 0.01). Data published
partially in reference 100.
loaded volunteers we found that acute administration of the
vasopressin analogue dDAVP consistently reduced both FENa
and FELl [100]. It is attractive to explain this effect (Fig. 4)
along the same lines as is done for indomethacin. Besides
having a hydroosmotic effect in the medullary collecting tubule,
vasopressin intensifies the cortico-medullary osmotic gradient
by decreasing papillary blood flow [94, 101, 102] and by
increasing NaCl reabsorption in the thick ascending limb [76,
99, 103—105], although the tatter effect may not occur in humans
[93]. It has been concluded by ourselves [100] and others [17]
that water loading does not increase FELl, which seems in
contrast with the observed effect of dDAVP. However, an
effect on FELl may only take place when the influence of
vasopressin is strong, thus when urine flow is very low. Neither
study considered such low urine flows.
A fall in FEL has been found in dogs during infusion of
angiotensin II in subpressor dose [27]. Since there is increasing
evidence that angiotensin stimulates sodium reabsorption in
proximal tubules [73], this is consistent with the lithium clear-
ance method. However, angiotensin II also reduces papillary
blood flow [94, 106, 107], which by increasing medullary
hypertonicity may promote water abstraction and sodium dif-
fusion from thin limbs of juxtamedullary loops of Henle [107].
Increased lithium reabsorption after angiotensin II may there-
fore have occurred in the tubule segment as well.
Finally, it should be considered that the disproportionate rise
in FELl during aforementioned mineralocorticoid escape in-
volved, besides suppressed reabsorption in proximal tubules,
decreased reabsorption of lithium in Henle's loop. Aldosterone
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Fig. 3. Fractional sodium and lithium excretion (FE,111,, and FE,,,,
before and after indomethacin (200 mg orally during preceding /8
hours) in healthy humans (N = 21) on varying sodium intakes. Means
SD are presented below the figure and were significantly different for
FElithium (P < 0.01). Detailed datain reference 96.
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stimulates sodium reabsorption primarily in the late distal and
cortical collecting tubules [1081. Escape from sodium retention
during its sustained use presumably depends on increased
sodium delivery to this segment [109]. Early micropuncture
studies in dogs showed, besides increased filtration, reduction
of the proximal fractional reabsorption [110], consistent with
the rise in maximal free water clearance which is invariably
found in mineralocorticoid escape [66, Ill, 112]. Later studies
localized the escape site in Henle's loop rather than the
proximal tubule [109, 113, 1141, supporting the possibility that
the large rise in FELl is at least partly due to reduced reabsorp-
tion in the loop.
Altogether there is rather strong evidence that lithium is
reabsorbed along Henle's loop, and that this reabsorption can
be influenced by dietary and pharmacological maneuvers. In
fact, data in humans indicate that the contribution to total
lithium reabsorption is not negligible, as will be considered
below.
Distal and collecting tubule
Lithium transport along distal and collecting tubule
The remainder of the "distal nephron", comprising distal
convoluted and connecting tubules, and cortical and medullary
collecting tubules, will be regarded together for practical pur-
pose. Net lithium transport in these segments would be zero if
the observation in rats that early distal fractional delivery of
lithium did not differ from FELl in the final urine [31] were
generally valid. However, this crucial finding concerns a single
study, and presumes no internephron heterogeneity. It is as-
sumed that sodium transport along the distal nephron concerns
active transcellular transport which depends on sodium extru-
sion out of the cell through the basolateral membrane by sodium
pumps, and passive luminal entry into the cell through sodium
channels [49, 50]. There is virtually no paracellular transport,
since this is a "tight" epithelium with high electrical resistance
and low sodium permeability [49, 50]. These characteristics
may not apply to the same extent to the papillary collecting duct
[50].
With respect to active lithium transport, our information is
limited. Lithium could not replace sodium in the electrogenic
transport mechanism in the turtle bladder [115] and the rabbit
cortical collecting tubule [1161, and replacement of luminal
sodium by lithium reduced proton excretion [115, 116]. This has
been related to the acidification defect caused by lithium in
humans [117] and dogs [1181. Yet there is compelling evidence
that, at least in certain conditions, lithium is actively reab-
sorbed somewhere along this segment, since U/PL ratio may
fall below unity. This has been encountered in stop-flow studies
in dogs undergoing mannitol diuresis [119], and in sodium-
restricted Brattleboro rats [51, 52]. In these rats, the low U/PLI
ratio was accompanied by a sharp fall in FELl. As mentioned,
such a sharp fall in FELl also exists in sodium-restricted normal
rats (Fig. 1), and in dogs [54]. In these species sodium restric-
tion apparently enhances this active lithium reabsorption in the
distal nephron. By contrast, in sodium restricted humans we
could neither establish a sharp fall in FEL, nor a U/PLI ratio
below 1.0, even when FENa was below 0.1% [54].
That lithium can enter tubule cells of the distal nephron at the
luminal side through the sodium channels is likely in view of
studies with amiloride (see below). Passive basolateral mem-
brane permeability to lithium, like that to sodium, is probably
low [45] but direct evidence is not available at present. During
antidiuresis the U/PLI ratio exceeds 30 in humans [100] and is as
high as 80 in rats [81]. In the latter study, the gradient between
lithium concentration in urine and inner medullary tissue ap-
proximated 6 during normal diuresis and 12 during vasopressin-
antidiuresis. Important passive permeability to lithium any-
where along the collecting tubules then seems unlikely.
Lithium clearance and interventions
Thiazides have been used to reveal potential lithium transport
in the distal tubule, which is the main target of these drugs.
However, most thiazides also have an inhibitory action on
carbonic anhydrase, and thus on proximal tubule solute reab-
sorption [120]. This would explain the modest rise in FELl in
rats after chlorothiazide [33], and absence of such an effect after
hydrochlorothiazide, which lacks carbonic anhydrase inhibiting
properties [52]. It is unclear why cyclopenthiazide, which also
inhibits carbonic anhydrase [120], did not increase FELl in
another study in rats [32]. In any case, these data seem to deny
thiazide-sensitive lithium reabsorption in the rat distal nephron.
This probably holds for humans as well. We recently found that
bendroflumethiazide, which virtually lacks carbonic anhydrase
activity [120], had no acute effect on lithium excretion in
healthy humans [121]. By contrast, chlorothiazide, which has
major carbonic anhydrase inhibiting activity, increased the
excretion of lithium, and also of uric acid, bicarbonate and
water.
The main action of amiloride is to inhibit sodium entry
through apical membrane channels from lumen into late distal
and collecting tubule cells [122—124]. Since amiloride inhibits
both sodium and lithium entry into epithelial cells of the toad
bladder [125, 126] and frog skin [1271, it is likely that these ions
compete for these channels in the late distal and/or collecting
tubule. In rat cortical collecting tubules these channels were
more permeable to lithium than to sodium [128]. Amiloride had
no influence on FELl in rats on regular diet [52], but almost
abolished the large fall in FELl which occurred during sodium
restriction [47, 52]. Identical observations were made in the dog
[54]. Also in sodium restricted rats, the discrepancy between
FELl and micropuncture-assessed end-proximal tubule delivery
disappeared after amiloride [47]. In humans, amiloride did not
(or hardly) affect FELl. Only during sodium restriction a very
small rise in FEL was found in one recent study [13]. We found
no effect on FELl in sodium restricted humans ourselves,
although the dose given was sufficient to produce a rise in
sodium excretion and a fall in potassium and acid excretion
[63].
Amiloride also interferes with the Na/H exchanger in the
proximal tubule [122, 124], and lithium may serve as alternative
substrate for this exchanger [129]. However, manifold higher
dosages are required than for the effect in the distal nephron
[122, 124, 130], which makes it less likely that the rise in lithium
excretion reflects an effect of amiloride on the proximal tubule.
The specificity of amiloride-sensitive channels for sodium
versus other cations probably differs among tissues [131]. The
above-mentioned observations would suggest low apical mem-
brane permeability for lithium in humans compared to rats and
dogs. Alternatively, lithium extrusion through the basolateral
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membrane may be relatively low in man. Humans share with
other mammals that a renal concentration disturbance develops
with chronic [117, 1321 or even acute [38] lithium administra-
tion. Studies in rabbits showed that uptake of lithium in cortical
collecting tubule cells through the apical membrane is essential
for the interference with the hydroosmotic effect of vasopressin
[133]. Interestingly, amiloride was shown to mitigate the con-
centration disturbance caused acutely after lithium administra-
tion to non-human primates [39]. Thus, the discrepant finding of
a rise in FELl after amiloride in rats and dogs but not in humans
may concern a difference in passage of lithium through the
basolateral membrane rather than the apical membrane of
collecting tubule cells.
Micropuncture studies in various rodents have shown that
addition of vasopressin increases and of prostaglandins de-
creases NaCI reabsorption in the cortical collecting tubule [89,
92, 134, 135]. Therefore it cannot be excluded that the decrease
in FELl seen in humans after dDAVP [100] and indomethacin
[88] was established (partly) in this tubular segment. Recent
studies in rats showed that the stimulation of sodium reabsorp-
tion in the cortical collecting tubule by vasopressin was entirely
effected by increasing sodium permeability through the apical
membrane, and could be blocked by amiloride [134]. It is
unknown whether amiloride is able to prevent the fall in FELl
which occurs in humans after dDAVP [1001.
Finally aldosterone, known to stimulate sodium reabsorption
in the late distal tubule and cortical collecting duct [108], did not
have any direct effect on lithium excretion in adrenalectomized
rats [29].
In sum, in the distal nephron neither passive nor thiazide-
sensitive or aldosterone-sensitive active lithium transport takes
place. Active reabsorption of lithium seems likely in salt
restricted rats and dogs, but not in man. The latter can be
inhibited by amiloride, probably by blocking cellular entry of
lithium through apical sodium channels.
The possibility of tubular lithium secretion
Tubular secretion of lithium would obviously invalidate the
lithium concept. This possibility might be considered when
lithium excretion is very large compared to sodium and water
excretion, such as occurs after furosemide. Kirchner found in
rats that after furosemide FELl became larger than the fluid
delivery at the superficial late proximal tubule assessed by
micropuncture [47]. In water-loaded humans we found that
furosemide raised FEL1 by 25% to as much as 54% (Table I).
With abolishment of reabsorption in Henle's loop by furo-
semide, fractional delivery of sodium and fluid out of this
segment would approximate FELl. The further data in Table 1
would then imply reabsorption of very large amounts of sodium
and water in the remainder nephron. Especially the latter may
be hard to imagine in the absence of an osmotic gradient and
with suppressed vasopressin.
As discussed, the finding by Kirchner in rats [47] may
concern a difference between superficial and deep nephrons.
Our finding in humans may be explained by assuming that
beyond Henle's loop water reabsorption occurred along the
osmotic gradient developed locally by accelerated solute reab-
sorption. Alternatively, it may be assumed that lithium either
was not reabsorbed in proportion to sodium in the proximal
tubules, or entered the tubular lumen somewhere beyond this
level. The former possibility, though not completely inconceiv-
able since proximal lithium reabsorption depends upon a con-
centration gradient, is denied by direct studies of proximal
lithium transport mentioned earlier [31, 44]. The latter possibil-
ity conflicts with the observation in rats that fractional lithium
delivery to the early distal tubule equalled total kidney FEL1
[31].
The feasible pathways for lithium secretion would be para-
cellular or transcellular. An appropriately large lumen-negative
voltage required for paracellular transport may exist in cortical
collecting tubules, but the shunt is too impermeable [49, 50].
The transcellular pathway would require a lithium concentra-
tion in tubule cells in excess of the tubule fluid concentration.
Since the latter exceeds the plasma concentration, this requires
active uptake across the basolateral membrane. If the uptake
was occurring via the (Na+K)-ATPase a high affinity of the
K-binding site would have to be postulated. This, however, is
not the case [136]. The option of lithium transport by the
Na/H exchange is also unlikely, as this would rather remove
lithium out of the cell and not move it in. Finally, lithium might
enter the cells through K-channe1s. Whereas no direct data on
basolateral K-channels and their lithium permeability are
available as yet, comparison with other epithelial K-channels
[137] would suggest that this again is unlikely. Therefore, we
would argue that currently there is very little in favor of a
lithium secretory mechanism.
Quantitative considerations
It will be clear from the foregoing discussion that changes in
FELl will not always (purely) reflect changes in proximal tubule
sodium handling. In this paragraph we will outline the possible
quantitative consequences for the lithium clearance method.
Loop of Henle
The fall in FEL during indomethacin administration was
about 7 to 10% in our study in humans (Table 1) and of
comparable magnitude in rats [98]. Most likely this concerns
enhanced lithium reabsorption in Henle's loop. In humans
during mineralocorticoid escape the FELl (Table 1) was at least
7 to 10% higher than during comparable expansion in other
models in humans [60, 67]. A similarly large FELl was found in
rats [64]. If this reflects a decreased reabsorption fraction in
Henle's loop as a contribution to escape [109], then this amount
at least is normally reabsorbed in this segment. Based on these
two situations we should consider with regard to humans and
rats: 1) an extreme range of lithium reabsorption in Henle's loop
of 0 to 15% of the lithium filtered, or one-fifth of the total lithium
reabsorption; and 2) that under normal conditions about 7% of
filtered lithium, or one-tenth of total lithium reabsorption, is
taken up here. This contention seems at variance with the good
agreement between FEL, and end-proximal tubule delivery in
rat superficial nephrons [47]. However, in view of the large
inter-nephron heterogeneity, in particular with respect to the
function of Henle's loop [49, 77, 78], lithium reabsorption in the
loop may preferentially occur in deeper nephrons. As sodium
reabsorption in the loop is much larger, alleged lithium uptake
and sodium uptake in this segment are not proportional.
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Distal and collecting tubule
As acknowledged by others, the extreme fall in FEL during
sodium restriction in rats and dogs probably reflects reabsorp-
tion in distal and collecting tubules, and can be prevented by
amiloride [47, 52, 54]. In this situation amiloride may increase
FELl by as much as 10% [47, 54], which gives an idea of the
quantitative importance of this problem. The estimated limit of
FENa below which this problem arose was 0.65% [47] or 0.4%
[52] in individual rat studies. The data collected in Figure 1
would indicate an FENa value 1.0% as a safer limit in rats. For
the dog this limit may be somewhat lower [54].
Summary and conclusions
Estimations of proximal tubule sodium reabsorption with the
FELl method come closer to direct measurements than any
other indirect method. There is little doubt that most lithium
reabsorption takes place in the proximal tubules, very likely in
proportion to the reabsorption of sodium and water. It is also
likely that changes in proximal tubule sodium reabsorption due
to changes in volume status are paralleled by changes in
proximal tubule lithium reabsorption, at least in the superficial
nephrons. Nonetheless, changes in FELl probably do not purely
reflect changes in proximal reabsorption, since lithium is also
handled beyond the proximal tubules.
Acknowledged problems are lithium reabsorption in Henle's
loop and in the late distal and collecting tubules. The latter
occurs in the rat and the dog, but not or much less in men.
Sodium restriction enhances this lithium transport consider-
ably. It is as yet uncertain whether other conditions, such as
increased vasopressin activity or lowering of renal perfusion
pressure, also influence this transport. Amiloride appears to
prevent this reabsorption of lithium. Therefore, this drug can be
used in lithium clearance studies whenever unwanted 'distal"
lithium reabsorption is expected. Lithium reabsorption in Hen-
le's loop forms a greater problem as it cannot be prevented by
any drug without influencing proximal tubule reabsorption. It is
estimated that about 7% of the filtered lithium (one-tenth of
total lithium reabsorption) is normally taken up here, preferen-
tially in deep nephrons. In view of studies with furosemide, this
reabsorption probably varies with sodium intake, but the pro-
portion of this variation to that of proximal tubule lithium
reabsorption is obscure. This remains an uncertain factor in any
circumstance where the lithium clearance method is used, In
some conditions the change in FELl may be so large relative to
the expected changes in proximal reabsorption, that use of FELl
as marker of end-proximal solute delivery seems unjustified.
Disproportionately large suppression is likely during mineralo-
corticoid-induced volume expansion, and stimulation during
prostaglandin synthesis inhibition and vasopressin. Based on
observations in these conditions the potential range of lithium
reabsorption in the loop of Henle would be 0 to 15% of filtered
load.
In this review attention was paid mainly to the validity of
lithium clearance as a pure 'proximal marker". Many of our
interpretations suffer from incomplete certainty with respect to
the renal effects of tested maneuvers, a problem which is
acknowledged. Direct studies on tubular lithium handling are
required before the lithium clearance method can be appreci-
ated fully, but even then species differences should be taken
into account. With these reservations, we conclude that the
method has its drawbacks, yet can be a precious tool in the
hands of the investigator conscious of these limitations. Even
though it may not claim the title of "proximal marker" fully,
study of lithium clearance may give important information. For
example, the fact that normal subjects can have exactly equal
FENa while displaying wide variation in FELl stresses that
individuals establish a certain sodium excretion rate through
markedly different ways of renal sodium handling. Also, species
differences in lithium handling may give clues with respect to
comparative renal physiology.
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